0001235802-12-000025.txt : 20120127 0001235802-12-000025.hdr.sgml : 20120127 20120127163348 ACCESSION NUMBER: 0001235802-12-000025 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20120125 FILED AS OF DATE: 20120127 DATE AS OF CHANGE: 20120127 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: DONENBERG PHILIP B CENTRAL INDEX KEY: 0001238120 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-31812 FILM NUMBER: 12552247 MAIL ADDRESS: STREET 1: 111 BARCLAY BLVD STREET 2: SUITE 280 CITY: LINCOLNSHIRE STATE: IL ZIP: 60069 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: BIOSANTE PHARMACEUTICALS INC CENTRAL INDEX KEY: 0001023024 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 582301143 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 111 BARCLAY BLVD CITY: LINCOLNSHIRE STATE: IL ZIP: 60069 BUSINESS PHONE: 8474780500 MAIL ADDRESS: STREET 1: 111 BARCLAY BLVD CITY: LINCOLNSHIRE STATE: IL ZIP: 60069 FORMER COMPANY: FORMER CONFORMED NAME: BEN ABRAHAM TECHNOLOGIES INC DATE OF NAME CHANGE: 19991027 4 1 primary_doc.xml PRIMARY DOCUMENT X0304 4 2012-01-25 0 0001023024 BIOSANTE PHARMACEUTICALS INC BPAX 0001238120 DONENBERG PHILIP B 111 BARCLAY BLVD LINCOLNSHIRE IL 60069 0 1 0 0 Sr VP of Finance, CFO, Secy Common Stock 44322 D Employee Stock Option (right to buy) 0.6844 2012-01-25 4 A 0 285000 0 A 2022-01-24 Common Stock 285000 285000 D This option vests with respect to 71,250 shares on each of January 25, 2013, January 25, 2014, January 25, 2015 and January 25, 2016. /s/ Phillip B. Donenberg 2012-01-26